SCHEMBL2452467

SCHEMBL2452467

N[CH]CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1101156 0.70
Hydrochloric Acid SCHEMBL10813408 0.67
SCHEMBL16732706 0.59
SCHEMBL5888410 0.59
SCHEMBL3496828 0.59
SCHEMBL15434551 0.59
SCHEMBL741909 0.59
SCHEMBL69372 0.59
SCHEMBL7631468 0.59
SCHEMBL5058095 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889053-A ANTICARCINOGENIC AGENTS RHONE-POULENC RORER S.A. (FR) 1999-03-30 US claimed
EP-0764149-B1 NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME RHONE POULENC RORER SA (FR) 1999-01-20 EP claimed
US-5861529-A ANTICANCER AGENTS RHONE-POULENC RORER S.A. (FR) 1999-01-19 US claimed
US-5856439-A ANTICANCER AGENT RHONE-POULENC RORER S.A. (FR) 1999-01-05 US claimed
US-5750567-A TETRAHYDRONAPHTHYL DERIVATIVES PHONE-POULENC RORER SA. (FR) 1998-05-12 US claimed
WO-2024120466-A1 MONOSACCARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS SURIO THERAPEUTICS CO., LTD (CN) 2024-06-13 WO disclosed
CN-101560172-B Nitrone free radical probe derived from chiral amino acid and preparation method thereof CHINESE ACAD INST CHEMISTRY 2012-03-07 CN disclosed
US-20110226620-A1 Highly Homogeneous Molecular Markers for Electrophoresis Life Technologies Corporation (US) 2011-09-22 US disclosed
CN-101560172-A Nitrone free radical probe derived from chiral amino acid and preparation method thereof INST OF CHEMICAL CAS (CN) 2009-10-21 CN disclosed
US-20070290173-A1 HIGHLY HOMOGENOEOUS MOLECULAR MARKERS FOR ELECTROPHORESIS INVITROGEN CORPORATION (US) 2007-12-20 US disclosed
EP-1485406-A4 HIGHLY HOMOGENEOUS MOLECULAR MARKERS FOR ELECTROPHORESIS INVITROGEN CORP (US) 2006-02-01 EP disclosed
EP-1307214-A4 HIGHLY HOMOGENEOUS MOLECULAR MARKERS FOR ELECTROPHORESIS INVITROGEN CORP (US) 2006-01-18 EP disclosed
US-5750567-A TETRAHYDRONAPHTHYL DERIVATIVES PHONE-POULENC RORER SA. (FR) 1998-05-12 US disclosed
EP-0650473-B1 RADIOIMAGING AND RADIOCHEMOTHERAPY PHENOLIC THIOETHER AMINES AND ACYL DERIVATIVES THEREOF FOR USE IN DIAGNOSING AND TREATING PIGMENTATION DISORDERS UNIV ALBERTA (CA) 1997-05-28 EP disclosed
EP-0515420-B1 NITRIC ACID ESTERS OF CYCLOHEXANOL DERIVATIVES BOEHRINGER MANNHEIM GMBH (DE) 1996-06-12 EP disclosed
EP-0650473-A1 RADIOIMAGING AND RADIOCHEMOTHERAPY PHENOLIC THIOETHER AMINES AND ACYL DERIVATIVES THEREOF FOR USE IN DIAGNOSING AND TREATING PIGMENTATION DISORDERS. UNIV ALBERTA (CA) 1995-05-03 EP disclosed
US-5411989-A Cardiovascular disorders BOEHRINGER MANNHEIM, GMBH (DE) 1995-05-02 US disclosed
US-5344753-A Colorimetric analysis, reaction of coupler with pyrazole ring with oxidized substrate to form dye EASTMAN KODAK COMPANY (US) 1994-09-06 US disclosed
WO-1994002456-A1 RADIOIMAGING AND RADIOCHEMOTHERAPY PHENOLIC THIOETHER AMINES AND ACYL DERIVATIVES THEREOF FOR USE IN DIAGNOSING AND TREATING PIGMENTATION DISORDERS THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 1994-02-03 WO disclosed
EP-0573100-A1 Dry analytical element and method for the detection of an aminopeptidase or transpeptidase Johnson &amp; Johnson Clinical Diagnostics, Inc. (US) 1993-12-08 EP disclosed